CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Symbion Research International

Symbion Research International is a Agoura Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Upfront Healthcare Services

Upfront`s Care Traffic Control platform proactively reassures and directs patients to the safest and most relevant care options within the health system.

Dove Tree Medical Staffing

Dove Tree Medical Staffing is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sunderstorm

Sunderstorm is a premier California-based lifestyle cannabis manufacturer focused on quality of products, quality of life, and quality of community.

Oakwood Place Assisted Living

Oakwood Place Assisted Living is a Davenport, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.